BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35697066)

  • 1. [Type-2-diabetes and gastrointestinal cancer screening].
    Scherübl H
    Z Gastroenterol; 2023 Jun; 61(6):683-689. PubMed ID: 35697066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Type-2-diabetes and cancer risk].
    Scherübl H
    Dtsch Med Wochenschr; 2021 Sep; 146(18):1218-1225. PubMed ID: 34521128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic syndrome and gastrointestinal cancer screening].
    Scherübl H
    Z Gastroenterol; 2023 Oct; 61(10):1394-1400. PubMed ID: 36379464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers.
    Kandimalla R; Xu J; Link A; Matsuyama T; Yamamura K; Parker MI; Uetake H; Balaguer F; Borazanci E; Tsai S; Evans D; Meltzer SJ; Baba H; Brand R; Von Hoff D; Li W; Goel A
    Clin Cancer Res; 2021 Nov; 27(22):6135-6144. PubMed ID: 34465601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal cancer characteristics in Lebanon.
    Antoine AR; Joyce S; Joanna S; Christine K; Khoury Salem E; Philippe S
    Arab J Gastroenterol; 2022 Feb; 23(1):52-57. PubMed ID: 34509388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal-type gastrointestinal adenocarcinoma: a morphologically distinct entity with unfavourable prognosis.
    Arora K; Bal M; Shih A; Moy A; Zukerberg L; Brown I; Liu X; Kelly P; Oliva E; Mullen J; Ahn S; Kim KM; Deshpande V
    J Clin Pathol; 2018 Mar; 71(3):221-227. PubMed ID: 28814568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of HIV on Non-AIDS defining gastrointestinal malignancies: A review.
    Pumpalova YS; Segall L; Felli R; Bhatkhande G; Jacobson JS; Neugut AI
    Semin Oncol; 2021 Jun; 48(3):226-235. PubMed ID: 34593219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobacco Smoking and Gastrointestinal Cancer Risk.
    Scherübl H
    Visc Med; 2022 Jun; 38(3):217-222. PubMed ID: 35814979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK.
    de Jong RGPJ; Peeters PJHL; Burden AM; de Bruin ML; Haak HR; Masclee AAM; de Vries F; Janssen-Heijnen MLG
    Cancer Epidemiol; 2018 Jun; 54():104-111. PubMed ID: 29705628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus and the risk of gastrointestinal cancer in women compared with men: a meta-analysis of cohort studies.
    Fang HJ; Shan SB; Zhou YH; Zhong LY
    BMC Cancer; 2018 Apr; 18(1):422. PubMed ID: 29661174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased incidence of gastrointestinal cancers among patients with pyogenic liver abscess: a population-based cohort study.
    Lai HC; Lin CC; Cheng KS; Kao JT; Chou JW; Peng CY; Lai SW; Chen PC; Sung FC
    Gastroenterology; 2014 Jan; 146(1):129-37.e1. PubMed ID: 24095786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal Bleeding Due to Gastrointestinal Tract Malignancy: Natural History, Management, and Outcomes.
    Schatz RA; Rockey DC
    Dig Dis Sci; 2017 Feb; 62(2):491-501. PubMed ID: 28032204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal Cancer Stage at Diagnosis Before and During the COVID-19 Pandemic in Japan.
    Kuzuu K; Misawa N; Ashikari K; Kessoku T; Kato S; Hosono K; Yoneda M; Nonaka T; Matsushima S; Komatsu T; Nakajima A; Higurashi T
    JAMA Netw Open; 2021 Sep; 4(9):e2126334. PubMed ID: 34546368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABO blood type, diabetes and risk of gastrointestinal cancer in northern China.
    Gong Y; Yang YS; Zhang XM; Su M; Wang J; Han JD; Guo MZ
    World J Gastroenterol; 2012 Feb; 18(6):563-9. PubMed ID: 22363124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention in gastrointestinal adenocarcinoma: for few but not for all?
    Bazuro GE; Torino F; Gasparini G; Capurso L
    Minerva Gastroenterol Dietol; 2008 Dec; 54(4):429-44. PubMed ID: 19047983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of CA 19-9 (carbohydrate antigen) in gastrointestinal adenocarcinoma.
    Mennini G; Silecchia G; Zanna C; Cucchiara G; Spadaro G; Greco E; Basoli A; Speranza V
    Ital J Surg Sci; 1985; 15(1):37-43. PubMed ID: 3858272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex- and site-specific differences in colorectal cancer risk among people with type 2 diabetes.
    Overbeek JA; Kuiper JG; van der Heijden AAWA; Labots M; Haug U; Herings RMC; Nijpels G
    Int J Colorectal Dis; 2019 Feb; 34(2):269-276. PubMed ID: 30421309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Oral and Upper Gastrointestinal Cancers in Persons With Positive Results From a Fecal Immunochemical Test in a Colorectal Cancer Screening Program.
    van der Vlugt M; Grobbee EJ; Bossuyt PM; Bos ACRK; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1237-1243.e2. PubMed ID: 29427732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of type 2 diabetes and insulin resistance in people with HIV infection: Prevalence, incidence and associated factors.
    Bratt G; Brännström J; Missalidis C; Nyström T
    PLoS One; 2021; 16(6):e0254079. PubMed ID: 34191847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.